Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Lozenge vs IV for Prevention of Shivering in Cesarean Section
NCT07511491Recruiting
- Sponsor
- Tanta University
- Start
- Apr 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ondansetron (3 arms), sponsored by Tanta University. Primary endpoint: Incidence of shivering. Started Apr 2026; status: recruiting.
02
Drugs
ondansetron
Beyond the preview
Go deeper on NCT07511491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511491.